September 10, 2025
Study reveals new evidence, cost savings for common treatments for opioid use disorder in mothers and infants
Researchers found that while established medications for opioid use disorder in mothers are both superior and cost saving compared to alternative treatment pathways, buprenorphine produced the greatest health gains and cost savings for mothers and infants.
By Jake Lowary